NYSE:MRK

Merck Foundation Announces Grant to American Cancer Society to Improve Access to Cancer Care in Resource-Limited Settings

$1.99 Million Grant Supports Patient Navigation Initiative in Sub-Saharan Africa
Press Release

KENILWORTH, N.J., May 23, 2019 /3BL Media/ - The Merck Foundation (the Foundation) and the American Cancer Society (ACS) recently announced that the Foundation awarded a $1.99 million, five-year grant to ACS to improve support and access to care for people living with cancer in low-and-middle-income countries, particularly in sub-Saharan Africa. This funding will help ACS further develop its capacity development approach to expanding patient navigation to countries with a growing burden of cancer.

Merck Named as a "Best for Vets" Employer by Military Times for Fifth Consecutive Year

Article

Merck has been recognized by Military Times as a 2019 “Best for Vets” employer for the fifth consecutive year.  In its tenth year, the Best for Vets: Employers rankings evaluate

Merck Supports The Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN)

Blog
At Merck, we aspire to improve the health and wellness of people worldwide, and to expand access to our medicines and vaccines. As part of our ongoing commitment to fighting neglected tropical diseases, Merck has announced a $500,000 grant to the World Health Organization’s Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN).
 

Merck Announces “Safer Childbirth Cities” Initiative, Issues Call to Action to Reverse the Rise in U.S. Maternal Deaths

Merck for Mothers Commits Additional $10M to Support Locally Created Solutions to Improve Maternal Health and Reduce Disparities
Press Release

KENILWORTH, N.J., October 3 , 2018 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today a new effort to support cities across the country to help women have a healthy pregnancy and safe childbirth. The “Safer Childbirth Cities” initiative is intended to reduce the number of maternal deaths and life-threatening childbirth events and narrow disparities in maternal health outcomes in the U.S.

Merck Announces Findings from WHO-led Study of Investigational Heat-Stable Carbetocin for Preventing Excessive Bleeding After Childbirth

Press Release

KENILWORTH, N.J., June 27, 2018 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, through its Merck for Mothers initiative announced study results on an investigational heat-stable formulation of carbetocin for the prevention of excessive bleeding after childbirth, also known as postpartum haemorrhage (PPH).

Merck for Mothers May 2018 Newsletter | Leadership News, Evidence for Impact and More

Newsletter

MERCK FOR MOTHERS LEADERSHIP NEWS

Merck for Mothers lead Dr. Naveen Rao has announced his intent to retire on July 1. Dr. Rao has led Merck for Mothers since its inception, and was responsible for leveraging Merck's scientific and business expertise to accelerate the program's progress. Dr. Mary-Ann Etiebet, currently the executive director, will succeed Dr. Rao.

Click here to learn more.

EVIDENCE FOR IMPACT

Merck INFOGRAPHIC | Finding New Ways to Reduce Our Environmental Impact and Promote Sustainability

Multimedia with summary

The world’s resources are finite.  Over the next few decades the demand for energy, clean water and natural resources will increase substantially due to population growth and economic development.  As a result, there will be fewer resources available to support the world’s growing needs.  In addition, air and water pollution continue to adversely impact human health, causing respiratory and water-borne illnesses.  At Merck, we are working to find new ways to reduce our use of natural resources and lower our environmental impacts. 

Merck for Mothers Lead Dr. Naveen Rao Announces Intent to Retire, Effective July 1, 2018

Press Release

May 24, 2018 /3BL Media/ - Merck for Mothers lead Dr. Naveen Rao has announced his intent to retire, effective July 1. Dr. Rao initiated and led Merck for Mothers, Merck’s 10-year, $500 million initiative to reduce maternal mortality around the world. He was responsible for leveraging the company’s science and business expertise to accelerate progress in reaching the Sustainable Development Goals and advancing Merck’s mission to improve and save lives.

Pages

Subscribe to NYSE:MRK